USA Financial Formulas’s Albemarle ALB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$393K Buy
2,907
+2,590
+817% +$457K 0.07% 95
2026
Q1
$56.9K Buy
+317
New +$54.1K 0.01% 216
2024
Q2
Sell
-2,393
Closed -$315K 301
2024
Q1
$315K Buy
+2,393
New +$295K 0.05% 142
2023
Q4
Sell
-8
Closed -$1.36K 347
2023
Q3
$1.36K Hold
8
﹤0.01% 375
2023
Q2
$1.78K Hold
8
﹤0.01% 313
2023
Q1
$1.77K Buy
+8
New +$1.97K ﹤0.01% 232
2022
Q3
$3K Hold
10
﹤0.01% 140
2022
Q2
$2K Hold
10
﹤0.01% 185
2022
Q1
$2K Hold
10
﹤0.01% 219
2021
Q4
$2K Hold
10
﹤0.01% 251
2021
Q3
$2K Hold
10
﹤0.01% 306
2021
Q2
$2K Buy
10
+2
+25% +$323 ﹤0.01% 294
2021
Q1
$1K Buy
+8
New +$1.28K ﹤0.01% 283
2017
Q3
Sell
-30,985
Closed -$3.27M 247
2017
Q2
$3.27M Buy
30,985
+2,725
+10% +$296K 0.79% 45
2017
Q1
$2.98M Buy
+28,260
New +$2.75M 0.72% 49
2016
Q3
Sell
-5,567
Closed -$442K 225
2016
Q2
$442K Buy
+5,567
New +$409K 0.12% 141

Other funds holding ALB

USA Financial Formulas's ALB Position: Q2 2026 in Review

USA Financial Formulas increased its Albemarle (ALB) stake by 817% in Q2 2026, buying an estimated $457K and bringing the position to 2,907 shares worth $393K. The position accounts for 0.07% of the portfolio, ranked #95.

USA Financial Formulas first reported a position in ALB in Q2 2016 and has held it in 16 quarters since. The position peaked at $3.27M in Q2 2017. 942 funds tracked by Wall St. Rank hold ALB as of Q2 2026.

  • USA Financial Formulas held 2,907 shares of Albemarle worth $393K as of Q2 2026.
  • USA Financial Formulas bought 2,590 Albemarle shares in Q2 2026, an estimated $457K.
  • Albemarle made up 0.07% of USA Financial Formulas's portfolio in Q2 2026, its #95 holding.
  • USA Financial Formulas first reported a position in Albemarle in Q2 2016 and has held it in 16 quarters since.
  • USA Financial Formulas's Albemarle position peaked at $3.27M in Q2 2017.
  • 942 funds tracked by Wall St. Rank held Albemarle as of Q2 2026.

Based on USA Financial Formulas's 13F filing for Q2 2026, filed 4 Aug 2026.